Antimicrobials and lung infection Flashcards

1
Q

How do tetracyclines enter bacteria?

A
  • diffuse across outer cell membrane

- via active carrier mediated process through inner cell membrane (can be anaerobia, abscesses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the action of tetracyclines?

A
  • bacteriostatic, broad spectrum

- bind to 30s subunit and block mRNA, prevents tRNA from being added to peptide chain and preventing protein synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the pharmacokinetics of tetracyclines

A
  • given IM or IV a oral is slow
  • oral absorption is slowed by food (chelate metal ions in stomach)
  • enter most tissues and body fluids
  • generally don’t cross the BBB
  • cross placenta and secreted into milk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the adverse affects of tetracyclines on young animals?

A

Affects teeth and bone growth in foetus and neonate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How are chlor-, oxy- and tetracycline metabolised and excreted?

A
  • metabolism is minimal
  • excreted unchanged in urine and bile
  • undergo some enterohepatic recirculation (increases half like to 6-10hrs)
  • urinary excretion via glomerular filtration (impaired renal function will increase the half life)
  • long acting formulations persist at injection site
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the properties of mino and doxycycline?

A
  • semisynthetic derivatives of tetracycline
  • more lipid soluble
  • better brain, ocular tissue and bronchial secretion penetration
  • good absorption after oral administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is minocycline metabolised and excreted?

A

Some metabolism, excreted in bile and faeces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is doxycycline metabolised and excreted?

A
  • no renal excretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the toxicity of tetracyclines

A
  • well tolerated and can be used long ter,
  • broad spectrum suppression of intestinal flora can lead to superinfection with resistant pathogens
  • idiosyncratic liver damage in some animals is there is renal impairment
  • renal tubular damage
  • can be irritant
  • occasional anaphylaxis when given IV
  • deposited at sites of ossification in bone and teeth
  • photosensitivity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the clinical use of tetracyclines?

A
  • broad spectrum
  • useful in mixed bacterial infections (esp. in lungs)
  • doxy and monocycline have anti-inflammatory properties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are indications for use of tetracyclines?

A
  • Cattle - resp infections in calves, bovine pneumonia, anaplasmosis, udder infection
  • Sheep - Q fever, enzootic abortion, foot rot, pasteurella haemolitica pneumonia
  • Pigs - prevent and treat atrophic rhinitis and lower resp disease, eradicate leptospira
  • Cats and dogs - UTI, otitis externa, chlamydia, upper resp tract infection
  • Poultry - prevention adn treatment of enteric and resp infection (largely in feed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give examples of macrolide drugs

A
Erythtomycin
Tilmicosin
Tylosin
Spiramycin
Tulathromycin
*Mainly gram +ve, some -ve, bacteriostatic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the mechanism of action of the macrolides?

A

Act on 50s subunit by binding to the P site. This inhibits the movement of tRNA from the A site to the P site. No more AA can be added to the chain so protein synthesis is inhibited.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the general properties of macrolides?

A
  • High intracellular conc
  • Broad distribution in tissues
  • Don’t cross BBB
  • Enter and are concentrated in phagocytes (targeted to site of infection)
  • Decrease mucous production (decrease bacterial load in the lungs)
  • May enhance host immunomodulatory response
  • Anti-inflammatory actions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the pharmacokinetics of erythromycin?

A
  • Weak base (ion trapped in acidic fluids)
  • Available orally as base, sterate, phosphate salt or thiocyanate
  • High lipid solubility
  • Well distributed in tissues
  • Well abosrbed orally, unstable in gastric acid (coated)
  • Food lowers gastric absorption
  • Partly inactivated by hepatic metabolism
  • Urinary retention is low (<5%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the toxicity of erythromycin

A
  • One of safest antimicrobial drugs
  • Can be irritating (oral, IV, IM - severe pain)
  • GI disturbances are common (stimulates SM)
  • Serious in horses because of method of excretion
  • Good sub for beta lactam
17
Q

What are the properties of tylosin?

A

Better activity than erythromycin against mycoplasmas

18
Q

What are the properties of spiramycin?

A
  • Greatly concentrate in tissues
  • penetrates well into milk, lacrimal fluids, resp secretions
  • V long half life, persistent drug residues
  • only licensed for periodontal problems
19
Q

What are the properties of tilmicosin?

A
  • Concentrates in tissues

- Can cause rapid depletion of Ca, heart problems, can be fatal in some species (horses, goats, man)

20
Q

What are the clinical uses of common macrolides?

A
  • Alternative to penicillin in penicillin sensitive animals
  • Erythromycin - Campylobacter jejuni, mycoplasma
  • Resp disease in pigs, cattle, poultry
  • Spiramicin for peridontal infection in dogs and cats
  • Dysentry, penumonia in pigs, calves, poultry
21
Q

Name advanced generation macrolides and their properties

A

Azithromycin, clarithromycin, roxithromycin, tulathromycin

  • HIgh bioavailability following oral administration
  • Broader spectrum of activity
  • Longer half lives
  • Higher tissue concentrations allowing daily dosage
22
Q

What are the properties of tulathromycin?

A
  • DRAXXIN
  • Bovine and porcine resp disease
  • SC (cattle), IM (pigs)
  • high distribution and slow elimination
  • Good gram -ve spectrum
  • High conc in lung (neutrophils and alveolar macrophages)
23
Q

Give examples of fluoroquinolones

A
Enrofloxacin (Baytril)
Danofloxacin
Marbofloxacin
Difloxacin
Orbifloxacin
Ibafloxacin
24
Q

What is the mechanism of action of the fluoroquinolones?

A
  • Bactericidal
  • Enter bacteria through porins
  • Binds to topoisomerase IV and topoisomerase II (coils up DNA) and inhibits DNA replication
25
Q

What is the spectrum of activity of the fluoroquinolones?

A
  • Gram +ve and -ve (aerobes)
  • Intracellular bactera e.g. chlamydia, legionella, brucella
  • Mycoplasma
  • Inactive against obligate anaerobes
26
Q

Describe the pharmacokinetics of the fluoroquinolones

A
  • High oral availability and rapid absorption (80-100%)
  • Oral availability lower in ruminants, give IV/SC
  • Low protein binding
  • Enter phagocytes
  • High conc in tissues and fluids
  • Partial liver metabolism
  • Parent drugs and metabolites excreted in urine and bile
  • High urinary conc of parent drug
  • Enterohepatic recycling
  • Baytril metabolised to active metabolites which have antimicrobial activity
27
Q

What are the clinical uses of the fluoroquinolones?

A
  • Treatment of serious gram -ve infection
  • Use as first choice for UTI (Pseudomonas aeruginosa); prostate infection; skin, soft tissue, wound infection; serious resp infection; osteomyelitis by gram -ve aerobes
28
Q

What are the clinical uses of fluoroquinolones in SA?

A
  • Rabbits, mice, rats, exotics - skin and visceral infection

- Don’t cause GI disturbances

29
Q

Describe the toxicity adn interactions of the fluoroquinolones

A
  • Relatively safe
  • Erode weight bearing cartilage
  • Clearnace of other drugs metabolised in the liver may be reduced
  • Some CNS problems associated with GABA (exacerbate epilepsy)
  • Ocular problems in cars (enrofloxacin) - high doses and long term treatment
30
Q

What are the properties of enrofloxacin?

A
  • Broad spectrum
  • Rapidly kills bactera
  • High bioavailability and absorption
  • Tissue conc exceed plasma conc
  • Crosses placenta, aqueous humour and CSF
  • Low plasma protein binding
  • Predominantly renal excretion
31
Q

What are the properties of marbofloxacin?

A
  • V good for Enterobacteriaciae and Pasteurella
  • Adequate plasma levels maintained for 24hr after SC injection
  • Parent drug excreted in urine and faeces
  • Well tolerated in dogs and cats
  • Resp infection in cattle and pigs